This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Get In The Zone – The Entertainment Zone!

Our prior eAlert ("Santa Monica Greenlights 'Entertainment Zone' to Revitalize Third Street Promenade") described how California Senate Bill 969 authorizes a city or county to create...

United States Healthcare

N

Nossaman LLP

Medicaid Moratoria: CMS Directs State To Limit Provider Enrollment In Minnesota

CMS' action signals a broader federal focus on using provider enrollment moratoria to address perceived fraud risks.

United States Healthcare

FL

Foley & Lardner

The More Things Change, The More They Stay The Same: DOJ Announces Record False Claims Act Healthcare Enforcement Recovery For 2025

As the Department of Justice (DOJ) has established its enforcement priorities over the last year, companies in regulated industries have worked to balance risk and react to the government's areas of focus.

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

FDA Updates Two Digital Health Final Guidance Documents

On Jan. 6, 2026, the U.S. Food and Drug Administration (FDA) updated the final guidance documents General Wellness: Policy for Low Risk Devices (the General Wellness Guidance) and Clinical Decision...

United States Healthcare

GT

Greenberg Traurig, LLP

State Laws Emerge To Regulate Pharmacy Benefit Managers

United States Healthcare

KR

Kutak Rock LLP

FDA "Cuts Red Tape" On Clinical Decision Support Software And Wearable Products For General Wellness

United States Healthcare

AP

Arnold & Porter

"Talk Cleanly To Me"—Touting The Quality Of Your Skincare And Beauty Products While Mitigating Class Action Litigation Risk

United States Healthcare

LL

Loeb & Loeb LLP

Holland & Knight Health Dose: January 21, 2026

United States Healthcare

HK

Holland & Knight

Notes From The ABA's 2026 False Claims Act Mock Trial Institute

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

FDA In Flux — January 2026 Newsletter

United States Healthcare

M

Mintz

OIG Reels In The Employment Safe Harbor: Recent Advisory Opinion Signals Risks For Sign-On Bonuses In Home Care

United States Healthcare

PL

Polsinelli LLP

A Pivotal Moment For Patients And Independent Pharmacies: Congress Acts On PBM Reform With Bipartisan Legislation

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Medicare Advantage In Uncertain Times

United States Healthcare

FL

Foley & Lardner

Immigrant Access To Health Centers: Confronting Unknowns In The Administration's Revised Interpretation Of PRWORA

United States Healthcare

FL

Foley & Lardner

See more

Webinars

See More

Recorded on 20 Jan 2026 | 3:00 PM

2026 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CBA In-House Lawyers

TC

CBA In-House Lawyers

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

Get In The Zone – The Entertainment Zone!

Our prior eAlert ("Santa Monica Greenlights 'Entertainment Zone' to Revitalize Third Street Promenade") described how California Senate Bill 969 authorizes a city or county to create...

United States Healthcare

N

Nossaman LLP

Texas AG Cracks Down On COVID-19 Egg Price Gouging

Texas AG Ken Paxton settled with Cal-Maine Foods, Inc. to resolve allegations that the company engaged in price gouging by sharply increasing...

United States Consumer

CO

Cozen O'Connor

FDA Updates Two Digital Health Final Guidance Documents

On Jan. 6, 2026, the U.S. Food and Drug Administration (FDA) updated the final guidance documents General Wellness: Policy for Low Risk Devices (the General Wellness Guidance) and Clinical Decision...

United States Healthcare

GT

Greenberg Traurig, LLP

State Laws Emerge To Regulate Pharmacy Benefit Managers

United States Healthcare

KR

Kutak Rock LLP

DOJ's False Claims Act Report For FY 2025 Shows Biggest Total Monetary Recoveries Yet, Provides Insight On FY 2026 Priorities

United States Criminal

LM

Littler Mendelson

US Department Of Justice Announces US$6.8 Billion In Fiscal Year 2025 False Claims Act Recoveries

United States Government

KG

K&L Gates LLP

FDA "Cuts Red Tape" On Clinical Decision Support Software And Wearable Products For General Wellness

United States Healthcare

AP

Arnold & Porter

State AG News: Environmental Regulation, Consumer Protection, Patient Safety (January 8-14, 2026)

United States Environment

CM

Crowell & Moring LLP

"Talk Cleanly To Me"—Touting The Quality Of Your Skincare And Beauty Products While Mitigating Class Action Litigation Risk

United States Healthcare

LL

Loeb & Loeb LLP

See more

Healthcare

Medicaid Moratoria: CMS Directs State To Limit Provider Enrollment In Minnesota

CMS' action signals a broader federal focus on using provider enrollment moratoria to address perceived fraud risks.

United States Healthcare

FL

Foley & Lardner

The More Things Change, The More They Stay The Same: DOJ Announces Record False Claims Act Healthcare Enforcement Recovery For 2025

As the Department of Justice (DOJ) has established its enforcement priorities over the last year, companies in regulated industries have worked to balance risk and react to the government's areas of focus.

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

FDA Updates Two Digital Health Final Guidance Documents

On Jan. 6, 2026, the U.S. Food and Drug Administration (FDA) updated the final guidance documents General Wellness: Policy for Low Risk Devices (the General Wellness Guidance) and Clinical Decision...

United States Healthcare

GT

Greenberg Traurig, LLP

State Laws Emerge To Regulate Pharmacy Benefit Managers

United States Healthcare

KR

Kutak Rock LLP

DOJ's False Claims Act Report For FY 2025 Shows Biggest Total Monetary Recoveries Yet, Provides Insight On FY 2026 Priorities

United States Criminal

LM

Littler Mendelson

US Department Of Justice Announces US$6.8 Billion In Fiscal Year 2025 False Claims Act Recoveries

United States Government

KG

K&L Gates LLP

FDA "Cuts Red Tape" On Clinical Decision Support Software And Wearable Products For General Wellness

United States Healthcare

AP

Arnold & Porter

Preventing False Claims Act Retaliation Claims: What Every Company Should Know — EnforceMintz

United States Employment

M

Mintz

Holland & Knight Health Dose: January 21, 2026

United States Healthcare

HK

Holland & Knight

See more

Life Sciences, Biotechnology & Nanotechnology

FDA In Flux — January 2026 Newsletter

Welcome to FDA in Flux — A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and consumer product investment decisions and development strategies.

United States Healthcare

M

Mintz

A Smarter Approach To Evaluating AI Life Sciences Investments

Life sciences investment – particularly in artificial intelligence technologies (AI) and AI-enabled innovators – has reached an inflection point. An uncertain AI regulatory ecosystem...

United States Technology

SR

McDermott Will & Schulte

Immigrant Access To Health Centers: Confronting Unknowns In The Administration's Revised Interpretation Of PRWORA

In July 2025, multiple federal agencies announced a reinterpretation of provisions of the Personal Responsibility and Work Opportunity Reconciliation Act of 1996 (PRWORA)...

United States Healthcare

FL

Foley & Lardner

Q&A With Former US Attorney Erek L. Barron On Enforcement Trends, Qui Tam Risks, And Strategic Opportunities — EnforceMintz

United States Criminal

M

Mintz

To Monetize Or Not To Monetize? The Question Late-Stage Life Sciences Companies Should Be Asking

United States Healthcare

GP

Goodwin Procter LLP

Atlantic Biologicals Opioid DPA: DOJ Continues Ramp Up Of Criminal Corporate Healthcare Enforcement

United States Healthcare

CM

Crowell & Moring LLP

Supreme Court Grants Cert. Petition In Hikma / Amarin Skinny Labeling Case

United States IP

PL

Polsinelli LLP

ASP Reporting Gets A Major Update In The CY 2026 PFS

United States Healthcare

SR

McDermott Will & Schulte

Federal Government Continues Efforts To Prohibit Gender-affirming Care For Minors

United States Healthcare

SR

McDermott Will & Schulte

See more

Latest Videos

See more

Episode 37: Chanda Center For Health: Reimagining Access To And Delivery Of Long-term Disability Care (Podcast)

FL

Foley & Lardner

When Health Plans Become Health Leaders: Hillary Galyean Rewrites The Health Plan Playbook (Video)

AM

Alvarez & Marsal

Album 9: Track 12 Steady On – Trilliant Health (Part 2) (Podcast)

PL

Polsinelli LLP

Ready To Deal: What Healthcare Providers Need To Know Before Raising Capital Or Selling (Video)

SM

Sheppard Mullin Richter & Hampton

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

Upcoming Events

Texas Cannabis Policy Conference

United States Healthcare

FH

Foley Hoag LLP

Navigating Key Legal Agreements In Your ASC

United States Healthcare

HK

Holland & Knight

All In The Family - After The Wedding: AMC And Community Hospital Affiliations In Practice - American Health Law Association Academic Medical Centers Conference

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Arnold & Porter’s 2026 Life Sciences Future Forum

United States Healthcare

AP

Arnold & Porter

2026 Equity Capital Markets Outlook: Insights Into Life Sciences And Medical Devices

United States Healthcare

FH

Foley Hoag LLP

Speaking Engagement

Wealth Catalyst Salons: Freedom Capital Agency & Possibilities

United States Finance

FH

Foley Hoag LLP

Optimizing Pharma Operations In 340B And Beyond: Investor Opportunities And Compliance Considerations

United States Healthcare

SR

McDermott Will & Schulte

The Town Hall Table: From State Chapters To The U.S. Capitol

United States Healthcare

HK

Holland & Knight

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More